- Home
- GBR vs CELZ Comparison
GBR vs CELZ Comparison
Compare GBR & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBR
- CELZ
- Stock Information
- Founded
- GBR 1978
- CELZ 1998
- Country
- GBR United States
- CELZ United States
- Employees
- GBR N/A
- CELZ N/A
- Industry
- GBR Oil & Gas Production
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- GBR Energy
- CELZ Health Care
- Exchange
- GBR Nasdaq
- CELZ Nasdaq
- Market Cap
- GBR 4.6M
- CELZ 5.5M
- IPO Year
- GBR N/A
- CELZ N/A
- Fundamental
- Price
- GBR $0.93
- CELZ $2.39
- Analyst Decision
- GBR
- CELZ
- Analyst Count
- GBR 0
- CELZ 0
- Target Price
- GBR N/A
- CELZ N/A
- AVG Volume (30 Days)
- GBR 12.3K
- CELZ 46.0K
- Earning Date
- GBR 05-15-2025
- CELZ 05-09-2025
- Dividend Yield
- GBR N/A
- CELZ N/A
- EPS Growth
- GBR N/A
- CELZ N/A
- EPS
- GBR N/A
- CELZ N/A
- Revenue
- GBR $148,000.00
- CELZ $14,000.00
- Revenue This Year
- GBR N/A
- CELZ N/A
- Revenue Next Year
- GBR N/A
- CELZ N/A
- P/E Ratio
- GBR N/A
- CELZ N/A
- Revenue Growth
- GBR 3.50
- CELZ 55.56
- 52 Week Low
- GBR $0.67
- CELZ $1.69
- 52 Week High
- GBR $1.82
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- GBR 55.04
- CELZ 64.49
- Support Level
- GBR $0.84
- CELZ $2.22
- Resistance Level
- GBR $0.97
- CELZ $2.44
- Average True Range (ATR)
- GBR 0.06
- CELZ 0.12
- MACD
- GBR -0.00
- CELZ 0.05
- Stochastic Oscillator
- GBR 56.67
- CELZ 91.04
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.